PDA Launches Pharma Quality Culture Transformation Program with Regulatory Agency Briefings

Share Article

Industry participants can now enroll in the program and benefit from the tools that will transform their quality cultures.

Enroll now!

The Quality Culture Transformation Program will provide companies a road map to improvement.

The Parenteral Drug Association (PDA) is pleased to announce the official launch of its Quality Culture Transformation Program for pharmaceutical manufacturers. Enrollment in the Quality Culture Transformation Program gives companies access to four tools to measure and ultimately improve their commitment to quality.

Pharmaceutical regulatory agencies around the globe have shown a keen interest in the development of the PDA Quality Culture Transformation Program. The U.S. Food and Drug Administration and the UK Medicines and Healthcare Products Regulatory Agency lent experts to the volunteer task force that developed the Program. PDA will brief officials in the USFDA’s Center for Drugs Evaluation and Research on April 9 in Bethesda, Md. and MHRA officials on April 19 in London on the program’s elements. PDA already briefed officials from the Taiwan FDA earlier this year.

Industry can enroll in the Program. Openings are still available for all sessions, including the April 17-18 session in Mainz, Germany.

Once enrolled, companies will start with training via a PDA-run course. Next, they will receive PDA’s Assessment Tool to conduct a site self-assessment. Then, they will complete PDA’s quality culture survey. The program concludes with benchmarking report that analyzes where the company/site stands vis a vis other companies completing the program.

The PDA Quality Culture Transformation Program was developed via a pilot program in 2016-2017 that involved 43 sites and 24 companies, resulting in over 63 trained assessors and benchmarking data collected from over 9000 survey respondents. Pilot participants informed PDA that the program will provide companies a “road map for improvement.

About PDA – Connecting People, Science and Regulation®
The Parenteral Drug Association (PDA) is the leading global provider of science, technology and regulatory information and education for the pharmaceutical and biopharmaceutical community. Founded in 1946 as a nonprofit organization, PDA is committed to developing scientifically sound, practical technical information and resources to advance science and regulation through the expertise of more than 10,500 members worldwide. Go to http://www.pda.org/footer/about-pda to learn more.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Walter Morris
PDA, Inc.
+1 (301) 656-5900 Ext: 148
Email >
since: 09/2010
Follow >
Visit website